BioLargo, Inc. (BLGO)
OTCMKTS
· Delayed Price · Currency is USD
0.190
0.00 (0.00%)
Dec 24, 2024, 4:00 PM EST
BioLargo Company Description
BioLargo, Inc. invents, develops, and commercializes various platform technologies.
Its technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation.
The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.
BioLargo, Inc.
Country | United States |
Founded | 1991 |
Industry | Chemicals |
Sector | Materials |
Employees | 33 |
CEO | Dennis Calvert |
Contact Details
Address: 14921 Chestnut Street Westminster, Delaware 92683 United States | |
Phone | 888 400 2863 |
Website | biolargo.com |
Stock Details
Ticker Symbol | BLGO |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | USD |
ISIN Number | US09065A1007 |
SIC Code | 2860 |
Key Executives
Name | Position |
---|---|
Dennis P. Calvert | Chairman, President and Chief Executive Officer |
Charles K. Dargan II, C.F.A. | Chief Financial Officer |
Joseph L. Provenzano | Executive Vice President of Operations, Corporate Secretary and Director |
Kenneth Reay Code | Chief Science Officer and Director |
Alex Evans | Director of Corporate Communications |
Steven V. Harrison II | President of Clyra Medical Technologies Inc |
Randall Moore | President of BioLargo Engineering, Science and Technologies, LLC |
Dr. Richard Smith Ph.D. | President of BioLargo Canada, Inc. |
Tonya Chandler | President of BioLargo Equipment Solutions and Technologies, Inc. |